February 14, 2022
NOT-NS-22-106 - Notice of Change to NOT-NS-21-014 "Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination".
NOT-NS-21-014 - Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination
PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of a change to the Due Dates and Eligibility Criteria for NOT-NS-21-014 "Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination". Changes to the NOSI are shown below.
Currently Reads:
Key Dates:
Expiration Date: March 01, 2023
Application and Submission Information
Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.
-
PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
All instructions in the SF424 (R&R) Application Guide and PA-20-272 must be followed, with the following additions:
- Submission acceptance is continuous but will be reviewed in cohorts based on time of submission:
-
Application Acceptance Periods March 15, 2021 to May 31, 2021 June 1, 2021 to August 31, 2021 September 1, 2021 to November 30, 2021 December 1, 2021 to February 28, 2022 -
Submissions are due by 5:00 PM local time of applicant organization.
-
- For funding consideration, applicants must include NOT-NS-22-082 (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
- Eligibility criteria
- Only existing awardees of the BRAIN Initiative (including SBIR/STTR) are eligible to apply.
- BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) awardees are NOT eligible.
- In the first sentence of the Research Strategy, please state that the parent grant was awarded under the BRAIN Initiative and identify the specific FOA of the parent grant (e.g., RFA-NS-18-023) to facilitate process and tracking of the supplement application.
- Applicants are strongly encouraged to contact the program officer listed on the most recent Notice of Award of the parent award to confirm eligibility.
- Administrative supplements must support work within the scope of the original project of the eligible parent award but beyond original dissemination plans included in parent application.
- Applicants are strongly encouraged to notify the program officer listed on the most recent Notice of Award of the parent award as well as Dr. Kari Ashmont ([email protected]) that a request has been submitted in response to this FOA in order to facilitate efficient processing of the request.
- Awards made under this NOSI are limited to one per parent award.
- This supplement is for a small dissemination experience of promising technologies or resources. Broader dissemination efforts of well-proven technologies or resources may be more appropriate for RFA-NS-19-006.
Modified to Read (changes shown in bold italics):
Key Dates
Expiration Date: March 01, 2023
Application and Submission Information
Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.
-
PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
All instructions in the SF424 (R&R) Application Guide and PA-20-272 must be followed, with the following additions:
- Submission acceptance is continuous but will be reviewed in cohorts based on time of submission:
-
Application Acceptance Periods March 15, 2021 to May 31, 2021 June 1, 2021 to August 31, 2021 September 1, 2021 to November 30, 2021 December 1, 2021 to February 28, 2022 March 15, 2022 May 31, 2022
June 1, 2022 August 31, 2022
September 1, 2022 November 30, 2022
December 1, 2022 February 28, 2023
-
Submissions are due by 5:00 PM local time of applicant organization.
-
- For funding consideration, applicants must include NOT-NS-21-014 (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
- Eligibility criteria
- Only existing awardees of the BRAIN Initiative (including SBIR/STTR) are eligible to apply.
- To apply for an administrative supplement award under this NOSI, applicants must have received a prior grant from the NIH BRAIN Initiative which must be active at the time of submission. The efforts proposed in the supplement applications may extend beyond the competitive segment of the active parent award by up to 12 months, if a request for a non-competing extension of the final budget period of the parent award’s project period is submitted to and approved by the appropriate grants management officer, in writing, prior to a supplement award being issued and at least 30 days prior to the end of the final budget period of the parent award. Otherwise, the project period of the supplement application will be prorated to end concurrent with that of the parent award. Grants currently under no-cost extension are ineligible.
- BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) awardees are NOT eligible.
- In the first sentence of the Research Strategy, please state that the parent grant was awarded under the BRAIN Initiative and identify the specific FOA of the parent grant (e.g., RFA-NS-18-023) to facilitate process and tracking of the supplement application.
- Applicants are strongly encouraged to contact the program officer listed on the most recent Notice of Award of the parent award to confirm eligibility.
- Administrative supplements must support work within the scope of the original project of the eligible parent award but beyond original dissemination plans included in parent application.
- Applicants are strongly encouraged to notify the program officer listed on the most recent Notice of Award of the parent award as well as Dr. Kari Ashmont ([email protected]) that a request has been submitted in response to this FOA in order to facilitate efficient processing of the request.
- Awards made under this NOSI are limited to one per parent award.
- This supplement is for a small dissemination experience of promising technologies or resources. Broader dissemination efforts of well-proven technologies or resources may be more appropriate for RFA-NS-22-011.
All other aspects of this Notice of Special Interest remain unchanged.
Dr. Kari Ashmont
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: (301) 496-1779
Email: ([email protected])
and Human Services (HHS)
